Mara Aleksić

Prof. Dr. Mara Aleksić

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Bioelectrochemistry
Verified
Journal Article
Closed access
JRJelena Rupar
Jelena Rupar
MAMara Aleksić
Mara Aleksić
Vladimir DobričićVladimir Dobričić
Vladimir Dobričić
JBJasmina Brborić
Jasmina Brborić
OČOlivera Čudina
Olivera Čudina

24 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MSMilan Selaković
Milan Selaković
MAMara Aleksić
Mara Aleksić
JKJelena Kotur-Stevuljevic
Jelena Kotur-Stevuljevic
JRJelena Rupar
Jelena Rupar
BIBranka Ivkovic
Branka Ivkovic
Ivermectin (IVM) is a drug from the group of anthelmintics used in veterinary and human medicine. Recently, interest in IVM has increased as it has been used for the treatment of some malignant diseases, as well as viral infections caused by the Zika virus, HIV-1 and SARS-CoV-2. The electrochemical behaviour of IVM was investigated using cyclic (CV), differential pulse (DPV) and square wave voltammetry (SWV) at glassy carbon electrode (GCE). IVM showed independent oxidation and reduction processes. The effect of pH and scan rate indicated the irreversibility of all processes and confirmed the diffusion character of oxidation and reduction as an adsorption-controlled process. Mechanisms for IVM oxidation at the tetrahydrofuran ring and reduction of the 1,4-diene structure in the IVM molecule are proposed. The redox behaviour of IVM in a biological matrix (human serum pool) showed a pronounced antioxidant potential similar to that of Trolox during short incubation, whereas a prolonged stay among biomolecules and in the presence of an exogenous pro-oxidant (tert-butyl hydroperoxide, TBH) resulted in a loss of its antioxidant effect. The antioxidant potential of IVM was confirmed by voltametric methodology which is proposed for the first time.

11 November 2022 in Bioelectrochemistry
Verified
Journal Article
Closed access
JRJelena Rupar
Jelena Rupar
VDVladimir Dobričić
Vladimir Dobričić
JBJasmina Brborić
Jasmina Brborić
OČOlivera Čudina
Olivera Čudina
MAMara Aleksić
Mara Aleksić

5 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JBJelena Bošković
Jelena Bošković
Vladimir DobričićVladimir Dobričić
Vladimir Dobričić
JSJelena Savić
Jelena Savić
JRJelena Rupar
Jelena Rupar
MAMara Aleksić
Mara Aleksić
OČOlivera Čudina
Olivera Čudina
Evaluation of pharmacokinetic properties is a significant step at the early stages of drug development. In this study, an in vitro evaluation of the pharmacokinetic properties of five newly synthesized compounds was performed. These compounds belong to N-hydroxyurea and hydroxamic acid derivatives and analogs of NSAIDs indomethacin, flurbiprofen, diclofenac, ibuprofen, and naproxen (compounds 1, 2, 3, 11, and 12, respectively) with dual COX-2 and 5-LOX inhibitory activity. Two in vitro methods (biopartitioning micellar chromatography (BMC) and PAMPA) were used to evaluate passive gastrointestinal absorption, while high-performance affinity chromatography (HPAC) and differential pulse voltammetry (DPV) were used to evaluate binding to human serum albumin (HSA). The introduction of N-hydroxyurea and hydroxamic acid groups into the structure of NSAIDs decreases both expected passive gastrointestinal absorption (BMC k values were from 3.02 to 9.50, while for NSAIDs were from 5.29 to 13.36; PAMPA –logPe values were between 3.81 and 4.76, while for NSAIDs were ≤3.46) and HSA binding (HPAC logk values were from 2.03 to 9.54, while for NSAIDs were ≥11.03; DPV peak potential shifts were between 7 and 34, while for NSAIDs were ≥54). Structural modifications of all tested compounds that increase lipophilicity could be considered to enhance their passive gastrointestinal absorption. Considering lower expected HSA binding and higher lipophilicity of tested compounds compared to corresponding NSAIDs, it can be expected that the volume of distribution of compounds 1, 2, 3, 11, and 12 will be higher. Reduced HSA binding may also decrease interactions with other drugs in comparison to corresponding NSAIDs. All tested compounds showed significant microsomal instability (25.07–58.44% decrease in concentration) in comparison to indomethacin (14.47%) and diclofenac (20.99%).

15 July 2025 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
JRJelena Rupar
Jelena Rupar
Marija Popović-NikolićMarija Popović-Nikolić
Marija Popović-Nikolić
KNKatarina Nikolić
Katarina Nikolić
Vladimir DobričićVladimir Dobričić
Vladimir Dobričić
OČOlivera Čudina
Olivera Čudina
MAMara Aleksić
Mara Aleksić

28 June 2023 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MJMilan Jovanovic
Milan Jovanovic
KNKatarina Nikolic
Katarina Nikolic
MČMarija Čarapić
Marija Čarapić
MAMara Aleksić
Mara Aleksić